Immune Therapeutics Inc's ticker is IMUN and the CUSIP is 45252A107. A total of 2 filers reported holding Immune Therapeutics Inc in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 12,500 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 12,500 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -50.0% | 12,500 | -54.5% | 0.00% | – |
| Q1 2016 | $4,000 | -33.3% | 27,500 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | +100.0% | 27,500 | +120.0% | 0.00% | – |
| Q3 2015 | $3,000 | +200.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | -50.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAI Capital Management | 12,500 | $0 | 0.00% |
| GLENMEDE TRUST CO NA | 10,000 | $0 | 0.00% |